PASG's current price target is $ Learn why top analysts are making this stock forecast for Passage Bio at MarketBeat. Track Passage Bio Inc (PASG) Stock Price, Quote, latest community messages, chart, news and other stock related information. Passage Bio, Inc. (US:PASG) has 63 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These. PASSAGE BIO (PASG) reported Q1 earnings per share (EPS) of -$, beating estimates of -$ by %. In the same quarter last year, PASSAGE BIO's. The current price of PASG is USD — it has decreased by −% in the past 24 hours. Watch Passage Bio, Inc. stock price performance more closely on the.
Passage Bio · Latest news for Passage Bio (NASDAQ:PASG) Stock. Passage Bio Inc stock price live, this page displays NASDAQ PASG stock exchange data. View the PASG premarket stock price ahead of the market session. Genetic medicines company Passage Bio to offer million shares in IPO priced at $16 to $18 each. Is Passage Bio (NASDAQ:PASG) In A Good Position To Invest In Growth? (Simply Wall St.) +%. May Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. The latest Passage Bio stock prices, stock quotes, news, and PASG history to help you invest and trade smarter. Passage Bio Inc PASG:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date03/06/24 · 52 Week Low · Overview. Passage Bio is a clinical stage genetic medicines company on a mission to improve the lives of patients with neurodegenerative diseases. Find the latest Passage Bio, Inc. (PASG) stock quote, history, news and other vital information to help you with your stock trading and investing. Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Can Indians buy Passage Bio Inc shares? Yes, Indians can invest in the Passage Bio Inc (PASG) from India. With INDmoney, you can buy Passage Bio Inc at 0.
The Wall Street analyst predicted that Passage Bio's share price could reach $ by May 15, The average Passage Bio stock price prediction forecasts a. Stock Quote: NASDAQ GS: PASG ; Day's Open. $ ; Volume. , ; Intraday High. $ ; Intraday Low. $ ; Closing Price. $ Discover real-time Passage Bio, Inc. Common Stock (PASG) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Company Profile. Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. What was Passage Bio's price range in the past 12 months? Passage Bio lowest stock price was $ and its highest was $ in the past 12 months. In depth view into PASG (Passage Bio) stock including the latest price, news, dividend history, earnings information and financials. Overview. Passage Bio is a clinical stage genetic medicines company on a mission to improve the lives of patients with neurodegenerative diseases. Passage Bio Inc. ; 12 Month Change. % ; Day Range - ; 52 Wk Range - ; Volume, K ; Market Value, $M. stock performance, and corporate governance. Overview · News · Events and Presentations · Financials and Filings · Stock Information · Investor FAQs · Resources.
Stock Quote: NASDAQ GS: PASG ; Day's Open. $ ; Volume. , ; Intraday High. $ ; Intraday Low. $ ; Closing Price. $ Passage Bio has % upside potential, based on the analysts' average price target. Passage Bio has a consensus rating of Moderate Buy which is based on 2. PASG Passage Bio · High. · Low. · Volume. K · Open. · Pre Close. · Turnover. K · Turnover Ratio. % · P/E (Static). Loss. A high-level overview of Passage Bio, Inc. (PASG) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. Passage Bio Inc. (PASG). Passage Bio, Inc NASDAQ: PASG is a genetic medicines company focused on developing transformative therapies for central nervous system.
Discover real-time Passage Bio, Inc. Common Stock (PASG) stock prices, quotes, historical data, news, and Insights for informed trading and investment. About PASSAGE BIO (PASG) ; Price / earnings ratio. x ; Today's range. $ - $ ; Debt / equity. x ; 52 week range. $ - $ ; 5 year debt / equity. Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Is Passage Bio (NASDAQ:PASG) In A Good Position To Invest In Growth? (Simply Wall St.) +%. May Passage Bio (NASDAQ:PASG) Stock, Analyst Ratings, Price Targets, Forecasts. Passage Bio Inc has a consensus price target of $8 based on the ratings of 8. Passage Bio, Inc. (muscles-power.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Passage Bio, Inc. | Nasdaq: PASG. Find the latest institutional holdings data for Passage Bio, Inc. Common Stock (PASG) including shareholders, ownership summaries, and holding activities at. Does Passage Bio have a direct stock purchase. What is Passage Bio, Inc. stock price today? The current price of PASG is USD — it has increased by % in the past 24 hours. Watch Passage Bio, Inc. Thinking of buying or selling Passage Bio Inc stock that's listed in a currency different from your local one? Use our international stock ticker to check. Passage Bio Inc stock price live, this page displays NASDAQ PASG stock exchange data. View the PASG premarket stock price ahead of the market session. View Passage Bio, Inc. PASG stock quote prices, financial information, real-time forecasts, and company news from CNN. Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. stock performance, and corporate governance. Overview · News · Events and Presentations · Financials and Filings · Stock Information · Investor FAQs · Resources. Can Indians buy Passage Bio Inc shares? Yes, Indians can invest in the Passage Bio Inc (PASG) from India. With INDmoney, you can buy Passage Bio Inc at 0. Passage Bio (PASG) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. Passage Bio Inc. (PASG). Passage Bio, Inc NASDAQ: PASG is a genetic medicines company focused on developing transformative therapies for central nervous system. The latest Passage Bio stock prices, stock quotes, news, and PASG history to help you invest and trade smarter. PASG Passage Bio · High. · Low. · Volume. K · Open. · Pre Close. · Turnover. K · Turnover Ratio. % · P/E (Static). Loss. Stock analysis for Passage Bio Inc (PASG:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. stock performance, and corporate governance. Overview · News · Events and Presentations · Financials and Filings · Stock Information · Investor FAQs · Resources. AST SpaceMobile Inc. $ ASTS % ; Generation Bio Co. $ GBIO % ; Bristol-Myers Squibb Co. $ BMY % ; Alnylam Pharmaceuticals, Inc. $ Passage Bio, Inc. (US:PASG) has 63 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These. Key Stats · Market CapM · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change Track Passage Bio Inc (PASG) Stock Price, Quote, latest community messages, chart, news and other stock related information. Company Profile. Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. Passage Bio Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Genetic medicines company Passage Bio to offer million shares in IPO priced at $16 to $18 each.
Mock Stock Portfolio App | The Best Skin Tag Remover On The Market